THIS MONTH’S ISSUE

Read, save, and print articles from the current issue

ARTICLES

Chronological index
2013–2017

PRODUCT GUIDES

Compare all instruments
and software systems

DEPARTMENTS

Chronological index
2013–2017

WEBINARS

Register Now and
On Demand

Home » MARKETPLACE, Marketplace Archives

C. diff assay cleared for Liaison MDX, 11/17

 

November 2017—DiaSorin Molecular announced the U.S. introduction of the Simplexa C. difficile Direct Assay upon receiving clearance from the Food and Drug Administration. The new assay runs on the company’s Liaison MDX qPCR system, a scalable benchtop instrument that delivers qualitative and quantitative, sample-to-answer multianalyte results. The Simplexa assay detects the Clostridium difficile toxin B gene (tcdB) present in liquid or unformed stool samples.

DiaSorin Molecular, +39 0161 487 1

Print Friendly, PDF & Email
Tags:

X